Procainamide Side Effects: What to Expect and When to Call Your Doctor

Procainamide is a powerful antiarrhythmic drug that can save lives when cardiac arrhythmias threaten—but it comes with a serious list of potential side effects that patients and caregivers must understand. The FDA has issued boxed warnings for two of the most dangerous: blood disorders and drug-induced lupus. This guide explains what to expect, what to watch for, and when to seek immediate help.

FDA Boxed Warnings: The Most Serious Risks

Procainamide carries two FDA boxed warnings—the strongest safety label the FDA can apply:

Drug-Induced Lupus Erythematosus (DILE): Prolonged procainamide use often leads to a positive anti-nuclear antibody (ANA) test. Some patients develop a lupus-like syndrome with symptoms including joint pain, arthritis, fever, and chest discomfort (pleuritis). This typically resolves when procainamide is discontinued, but requires monitoring.

Serious Blood Disorders: Agranulocytosis (dangerously low white blood cells), leukopenia, neutropenia, thrombocytopenia, and aplastic anemia have been reported in approximately 0.5% of patients on procainamide—most within the first 3 months of treatment. These are potentially fatal: about 20–25% of reported agranulocytosis cases have resulted in death. Weekly complete blood counts (CBC) are required for the first 3 months.

Common Side Effects of Procainamide

These side effects are less dangerous but occur more frequently:

Hypotension (low blood pressure): Especially during IV infusion, procainamide can cause blood pressure to drop. Risk is higher at infusion rates above 20 mg/min. Blood pressure monitoring is required during IV administration.

Bradycardia (slow heart rate): Procainamide can slow the heart rate as it suppresses abnormal electrical conduction.

QRS/QT prolongation: Widening of the QRS complex and QT interval on ECG is expected with therapeutic doses. QRS widening greater than 25% may indicate toxicity. This effect is monitored with serial ECGs.

Drug fever and allergic reactions: Some patients experience drug fever, rash (maculopapular or urticaria), itching, or angioedema.

GI symptoms (with oral forms): Nausea, vomiting, diarrhea, and loss of appetite were commonly reported with oral procainamide tablets (now discontinued commercially).

Serious Side Effects: Seek Emergency Care or Call Your Doctor Immediately

Contact your doctor immediately or go to the emergency room if you experience any of the following:

Signs of infection: Fever, chills, sore throat, mouth sores, or unusual weakness—these may indicate agranulocytosis, a life-threatening drop in white blood cells

Unusual bruising or bleeding: Nosebleeds, bleeding gums, or bruising easily may signal thrombocytopenia

Joint pain, fever, or chest pain: May indicate drug-induced lupus erythematosus. Tell your doctor right away if you develop these symptoms while on procainamide.

New or worsening irregular heartbeat: Procainamide can paradoxically worsen arrhythmias in some patients. Palpitations, dizziness, or fainting require immediate evaluation.

Severe dizziness or fainting: May indicate hypotension or dangerous heart rhythm changes

Severe allergic reaction: Difficulty breathing, throat swelling, or hives—may indicate anaphylaxis, especially if the injectable contains sodium metabisulfite (a known allergen for some people)

Required Monitoring While on Procainamide

Because of its toxicity risks, procainamide therapy requires regular monitoring:

CBC (complete blood count): Weekly for the first 3 months, then periodically. This screens for agranulocytosis and other blood dyscrasias.

ANA titer: Baseline and periodic testing for drug-induced lupus. A positive ANA result requires reassessment of therapy.

Electrocardiogram (ECG): Serial ECGs to monitor QRS width, QTc interval, and PR interval—especially during IV infusion.

Renal function: Procainamide is primarily renally cleared. Patients with impaired kidney function need dose adjustments and more frequent monitoring.

Drug levels (procainamide and NAPA): Therapeutic plasma levels and monitoring for toxicity (level >12 mg/L may indicate toxicity).

39,049+ patients found their medications in stock

39K+

Find Procainamide In Stock Today →

Having Trouble Finding Procainamide at the Pharmacy?

Finding procainamide at a pharmacy can be challenging. medfinder calls pharmacies near you to find which ones have it in stock. Read more about procainamide availability in 2026 to understand why it can be hard to find.